Literature DB >> 9246017

Fuzzy logic pharmacokinetic modeling: application to lithium concentration prediction.

B A Sproule1, M Bazoon, K I Shulman, I B Turksen, C A Naranjo.   

Abstract

INTRODUCTION: We hypothesized that fuzzy logic could be used for pharmacokinetic modeling. Our objectives were to develop and evaluate a model for predicting serum lithium concentrations with fuzzy logic.
METHODS: Steady-state pharmacokinetic data had been previously collected in 10 elderly patients (age range, 67 to 80 years) with depression who were receiving lithium once daily. Each patient had serial serum lithium concentration determinations over one 24-hour period. The resulting 137 data sets initially consisted of five input variables (age, weight, serum creatinine, lithium dose, and time since last dose) and one output variable (serum lithium concentration; range, 0.2 to 1.24 mmol/L).
RESULTS: A fuzzy rulebase was created with 87 randomly chosen data sets, and predictions of serum lithium concentration were made on the basis of the remaining 50 data sets. All of the input variables except age and weight were identified as contributing to the fuzzy logic model. The average magnitude of the error in the predictions was 0.13 mmol/L (root mean squared error) with a bias (mean of the prediction errors) of 0.03 mmol/L.
CONCLUSIONS: This study indicates that the use of fuzzy logic for pharmacokinetic modeling of lithium for serum concentration predictions is feasible.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9246017     DOI: 10.1016/S0009-9236(97)90149-1

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  6 in total

1.  Fuzzy simulation of pharmacokinetic models: case study of whole body physiologically based model of diazepam.

Authors:  Ivelina I Gueorguieva; Ivan A Nestorov; Malcolm Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-06       Impact factor: 2.745

2.  Spline functions in convolutional modeling of verapamil bioavailability and bioequivalence. I: conceptual and numerical issues.

Authors:  J Popović
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Apr-Jun       Impact factor: 2.441

3.  Neuro-fuzzy models as an IVIVR tool and their applicability in generic drug development.

Authors:  Jerneja Opara; Igor Legen
Journal:  AAPS J       Date:  2014-01-30       Impact factor: 4.009

4.  Accuracy of the Pepin method to determine appropriate lithium dosages in healthy volunteers.

Authors:  E Stip; J Dufresne; B Boulerice; R Elie
Journal:  J Psychiatry Neurosci       Date:  2001-09       Impact factor: 6.186

5.  Fuzzy logic in medicine and bioinformatics.

Authors:  Angela Torres; Juan J Nieto
Journal:  J Biomed Biotechnol       Date:  2006

6.  Genetic fuzzy system predicting contractile reactivity patterns of small arteries.

Authors:  J Tang; M Sheykhzade; B F Clausen; H C M Boonen
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-04-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.